CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Biostem Technologies Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Biostem Technologies Inc
2836 Center Port Cir
Phone: (954) 380-8342p:954 380-8342 POMPANO BEACH, FL  33064-2136  United States Ticker: BSEMBSEM

Business Summary
BioStem Technologies, Inc. is focused on harnessing the natural properties of perinatal tissue in the development, manufacture and commercialization of allografts and regenerative therapies. Leveraging its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. Its products include VENDAJE, VENDAJE AC, VENDAJE OPTIC and AmnioWrap2. VENDAJE is a structural tissue allograft composed of the amnion layer of the placental membrane. VENDAJE is intended for homologous use as a protective covering for soft tissue wounds. VENDAJE AC is a thicker structural tissue allograft composed of the amnion and chorion layer of the placental membrane. VENDAJE AC is intended for homologous use as a protective covering for soft tissue wounds. VENDAJE OPTIC is a structural tissue allograft composed of the amnion layer of the placental membrane. AmnioWrap is a placental-based allografts comprised of unseparated amnion and chorion membranes, including the intact intermediate layer.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202312/31/2021YesYes--Yes

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board Thomas J.Dugan 12/13/2023 12/13/2023
President, Chief Executive Officer, Director MarcBarhonovich 42 11/1/1999 11/1/1999
Chief Financial Officer, Secretary, Treasurer, Director Leon F.Willis 70 12/1/1999 12/1/1999
7 additional Officers and Directors records available in full report.

Business Names
Business Name
Aladdin Trading & Co.
Beverly Hills LTD Inc.
BSEM
Caribbean Casino & Gaming Corp
CGAQD
Regenerative BioScience, Inc.

General Information
Number of Employees: 67 (As of 12/31/2010)
Outstanding Shares: 13,100,140 (As of 9/30/2023)
Shareholders: 432
Stock Exchange: OTC
Federal Tax Id: 870281305


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, April 16, 2024